News | Proton Therapy | September 21, 2015

IBA to Install Latin America’s First Proton Therapy Center in Argentina

Facility to begin treating patients at the end of 2018

September 21, 2015 — IBA (Ion Beam Applications SA) announced that it has signed a contract with the company INVAP for the installation of a proton therapy center at the Instituto de Oncologia Angel Roffo hospital in Buenos Aires, Argentina.

IBA will equip the new center with its ProteusPlus system, including one gantry treatment room with next-generation pencil beam scanning capability and one research and development room. The contract will also include an operation and maintenance agreement. The equipment and services that will be supplied by IBA are worth between EUR 35 and 40 million to IBA.

This first proton therapy center to be installed in Latin America is part of the implementation of the Nuclear Medicine National Plan of the Argentine Ministry of Federal Planning, Public Investment and Services, together with the Ministry of Health and the National Atomic Energy Commission (CNEA). The Nuclear Medicine National Plan is a unique government plan of investment in infrastructure and equipment designed to ensure free access to the highest standards in prevention, treatment, research and training in nuclear medicine and oncology. It is expected that the center will treat its first patient at the end of 2018.

The Argentine Minister of Federal Planning, Public Investment and Services, Julio De Vido, commented: "Bringing an innovative new cancer center closer to the people has the objective to give better chances to fight this severe disease. Argentina is the first country in Latin America to have access to this unique medical technology which will be beneficial for the health of patients in the country.”

For more information: www.iba-worldwide.com

Related Content

Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares
RayStation Selected for London's Charing Cross Hospital and Hammersmith Hospital
News | Treatment Planning | January 30, 2018
Imperial College Healthcare NHS Trust in London, U.K., has chosen RayStation as the sole treatment planning system for...
Overlay Init